Hjem › Eggstokkreft › California › Irvine
Kliniske studier for Eggstokkreft i Irvine, CA
12 studier for Eggstokkreft søker deltakere på steder i og rundt Irvine (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
RekruttererFase 2/3
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
RekruttererFase 1/2
- Research Site, Irvine
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
RekruttererFase 1
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 280914, Irvine
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
RekruttererFase 1/2
- The City of Hope Orange County Lennar Foundation Cancer Center, Irvine
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
RekruttererFase 3
- City of Hope Lennar, Irvine
- Kaiser Permanente Zion Medical Center, Irvine
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
RekruttererFase 1/2
- City of Hope, Irvine, Irvine
A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
Rekrutterer
- City of Hope at Irvine Lennar, Irvine
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Rekrutterer
- City of Hope at Irvine Lennar, Irvine
- Kaiser Permanente-Irvine, Irvine
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RekruttererFase 3
- Kaiser Permanente-Irvine, Irvine
An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
RekruttererFase 2
- City of Hope Lennar, Irvine
CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer
RekruttererFase 1/2
- City of Hope, Irvine
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Irvine
Eggstokkreft-studier i andre byer
- Houston, TX89 studier
- New York City, NY69 studier
- Boston, MA61 studier
- Los Angeles, CA50 studier
- Nashville, TN49 studier
- Arlington, VA46 studier
- Philadelphia, PA44 studier
- Columbus, OH39 studier
- St. Louis, MO38 studier
- Chicago, IL36 studier
- San Antonio, TX31 studier
- Cleveland, OH30 studier
Andre studier i Irvine
- Ikke-småcellet lungekreft25 studier
- Brystkreft23 studier
- Kreft (alle typer)17 studier
- Metastatisk kreft16 studier
- Lungekreft15 studier
- Multipelt myelom14 studier
- Prostatakreft14 studier
- Plateepitelcancer i hode og hals11 studier
- Blærekreft11 studier
- Alzheimers sykdom11 studier
- Kolorektal kreft10 studier
- Pankreaskreft10 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.